Longevity InTime BioTech Company

Longevity InTime™ is 4P medicine technology (Predictive, Preventive, Personalized, Participatory) of a real-time early stages diseases diagnosis by collecting and measuring human biodata online. With a hardware & software, a complex of wearable & Rapid Diagnostic Tests devices we plan to find & try to fight the diseases on the unknown before early stages, which affect longevity. With these devices we measure 400+ life essential parameters and with AI server predict & prevent some severe diseases, which shorten life up to 30 years. Our ML algorithms are trained with 70+ years Big Data of human clinical trials, collected in the structured way from leading medical databases such as PubMed & Mimic. We are beta testing BMI Disease Tracker in Google Play & AntiObesity in the App Store. Responding to the world's challenge we launched online self check up tracker, which can be downloaded from our website. All apps can help people to have a "second'' opinion on their condition. Our diversed 30 member team from 12 countries formed one of the biggest biotech startup with 0 salary burn rate. On Sequoia Capital website stated “it's not too early for us”, emphasizing that it’s never too early for them to invest, and the pool of companies to which they are related are valued at $3.3 trillion today. I invite you to bet on us, as they did on Apple in 1978.

Headquarters: Wilmington, Delaware, United States
Total Funding: 2400000
Founded Date: 2018-09-01
Employee Number: 51-100
Last Funding Type: Pre-Seed
Investor Type: For Profit
Investors Number: 2
Last Funding Date: 2020
Technology: Others
Funding Status: Seed
Estimated Revenue: $1M to $10M
Industry: Apps, Artificial Intelligence, Deep Diagnostics, Electronic Health Record (EHR), Health Diagnostics, Information Technology, Internet of Things, Life Science, Medical, Personal Health, Softwa